Immunocore Holdings PLC - ADR - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
IMCR Nasdaq 2834 http://www.immunocore.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Immunocore Holdings PLC - ADR

Immunocore announces upcoming presentation and posters at ASCO 2024 - Apr 24th, 2024 2:00 pm
Immunocore to present at upcoming investor conferences - Apr 4th, 2024 8:00 pm
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio - Mar 13th, 2024 3:07 pm
Immunocore presented two posters at CROI 2024 - Mar 5th, 2024 9:30 pm
Immunocore Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Mar 1st, 2024 10:34 am
Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript - Feb 29th, 2024 3:51 pm
Immunocore Holdings PLC (IMCR) Reports Strong Revenue Growth Amidst Expansion and Clinical ... - Feb 28th, 2024 9:53 pm
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update - Feb 28th, 2024 12:34 pm
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial - Feb 22nd, 2024 12:00 pm
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024 - Feb 21st, 2024 12:00 pm
Sarepta's (SRPT) DMD Drug sBLA Gets FDA's Priority Tag, Stock Up - Feb 19th, 2024 11:28 am
Zacks Industry Outlook Highlights Sarepta, Exelixis, Immunocore, Editas and Puma Biotechnology - Feb 14th, 2024 11:00 am
Zoetis' (ZTS) Q4 Earnings Miss Expectations, Sales Beat - Feb 13th, 2024 4:22 pm
5 Biotech Stocks to Consider for Your Portfolio in 2024 - Feb 13th, 2024 2:00 pm
Immunovant (IMVT) Up 3% as Q3 Earnings Top, Pipeline in Focus - Feb 13th, 2024 12:26 pm
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma - Feb 12th, 2024 2:13 pm
REGENXBIO's (RGNX) Hunter Syndrome Study Meets Goal, Stock Up - Feb 8th, 2024 2:36 pm
Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up - Feb 7th, 2024 1:34 pm
Deciphera (DCPH) Q4 Loss Narrower Than Expected, Revenues Beat - Feb 7th, 2024 1:28 pm
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last? - Feb 1st, 2024 10:16 am